Incretin-based Therapies (Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase - 4 Inhibitors) for the Treatment of Type 2 Diabetes

Incretin-based Therapies (Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase - 4 Inhibitors) for the Treatment of Type 2 Diabetes

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Canadian Journal of Diabetes - Volume 36, Issue 1, February 2012, Pages 9-14

Amir MB, BCh, FRCP, FACP, Vincent MD, FRCPC, Jean-François MD, CSPQ, Elaine M. BSc (Pharm) RPh CDE,